Topical Drug Delivery Market
Topical Drug Delivery Market Size, Share & Trends Analysis Report by Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products), by Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, and Nasal Drug Delivery), and by Facility of Use (Home Care Settings, Hospitals & Clinics, Burn Centers, and Other Facilities) Forecast Period (2022-2028) Update Available - Forecast 2024-2030
Topical drug delivery market is anticipated to grow at a significant CAGR of 6.1% during the forecast period. The key factors contributing to the market growth include the growing incidence of burn injuries attributed to which there is high adoption of topical drugs as it is one of the major application areas of topical drugs. For instance, in November 2021, according to the data provided by Lancet Public Health, burn is one of the major causes of disability, with more than 8 million disability-adjusted life-years (DALYs). Topical drugs are majorly used for effective burn treatment and management. Many antimicrobial agents for burn treatment are available that includes Fenistil (GSK), Sulfamylon cream (Mylan), and Bactroban (GSK), among others. Thus attributed to the increase in burn cases the demand for new research and drug development and delivery is increasing and directly positively impacting the market growth.
However, topical drugs may cause various side effects such as allergies, which is the major factor hampering the growth of the market. Additionally, the patients with pre-existing skin conditions are at a higher risk of developing such allergic reactions. Thus, the increasing self-administration of topical drugs in-home care is providing high opportunities for players operating in the topical drug delivery market.
Segmental Outlook
The global topical drug delivery market is segmented based on the product, route of administration, and facility of use. Based on product, the market is sub-segmented into semi-solid formulations, liquid formulations, solid formulations, and transdermal products. Semi-solid formulations include creams, ointments, lotions, gel, and pastes. Liquid formulations comprise suspensions and solutions. The solid formulation includes powders and suppositories. Further, the transdermal products include transdermal patches and semi-solid. Based on the route of administration, the market is sub-segmented into dermal drug delivery, ophthalmic drug delivery, rectal drug delivery, vaginal drug delivery, and nasal drug delivery. Based on the facility of use, the market is subdivided into home care settings, hospitals & clinics, burn centers, and other facilities. Among the route of administration, the dermal drug delivery segment is anticipated to hold a considerable share in the market due to several advantages offered to it. Some of the advantages include pain-free self-administration for patients, narrow therapeutic indices, elimination of frequent administration of drugs, and injections to maintain a constant drug concentration.
Among the transdermal product, the transdermal patches sub-segment is expected to hold a prominent share in the market. The advantages of transdermal medicine including excellent ease of administration among others coupled with the increasing incidences of several problems such as migraine, hormone disturbances, joint pain, and others are some prominent factor driving the segmental growth. Transdermal patches are non-invasive which decreases the inconvenience brought on by parenteral or intravenous therapies. As per the data provided by Amgen Inc., Migraine is a major global health issue. It affects an estimated number of 1 billion people globally, and is the second leading cause of people living with a disability. It also stated that in the prevalence of migraine in the US is 12%, majorly diagnosed in people aged between 30 to 49 years. Thus, owing to it the demand for non-invasive patches increasing to deliver the drug directly into the bloodstream through the skin.
Regional Outlooks
The global topical drug delivery market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East &Africa, and Latin America. North America is expected to hold a prominent share owing to the growing number of smokers in the region which in turn is increasing the demand for drugs and advancements in transdermal patches.
Global Topical Drug Delivery Market Growth, by Region 2022-2028
The Asia-Pacific Region is Fastest Growing in the Global Topical Drug Delivery Market
The region is anticipated to witness the fastest growth in the market owing to the increasing number of patients with skin disease and technological advancements, innovations along with the rising contribution of players in expansion and new launches. For instance, in July 2020, Teva Pharmaceuticals Industries Ltd., with Takeda, a joint business venture expanded its presence in Japan, which focuses on commercializing complex generics, specialty assets, and other offers pipeline opportunities under its new strategy for its local commercial operations. Furthermore, the growing awareness about the advantages offered by transdermal medicine demand is increasing in emerging countries such as India, Japan, and China among others are other factors contributing to the growth of the market.
Market Players Outlook
The major companies serving the global topical drug delivery market include AbbVie Inc., Glenmark Pharmaceuticals Ltd., Merck KGaA, Novartis International AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, geographical expansions, partnerships, product launches, and collaborations, to stay competitive in the market. For instance, in June 2022, Kindeva Drug Delivery accquired iPharma Labs, to expand clinical and commercial support for dry powder and nebulized respiratory therapies. This new acquisition supports customers from early research and development through clinical and commercial manufacturing inhalation technologies for delivery to the patient to and through the lungs.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global topical drug delivery market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. AbbVie Inc.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Glenmark Pharmaceuticals Ltd.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Merck KGaA
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Novartis International AG
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Teva Pharmaceutical Industries Ltd.
3.6.1. Overview
3.6.2. Financial Analysis
3.6.3. SWOT Analysis
3.6.4. Recent Developments
3.7. Key Strategy Analysis
4. Market Segmentation
4.1. Global Topical Drug Delivery Market By Product
4.1.1. Semi-Solid Formulations
4.1.1.1. Creams
4.1.1.2. Ointments
4.1.1.3. Lotions
4.1.1.4. Gel
4.1.1.5. Pastes
4.1.2. Liquid Formulations
4.1.2.1. Suspensions
4.1.2.2. Solutions
4.1.3. Solid Formulations
4.1.3.1. Powders
4.1.3.2. Suppositories
4.1.4. Transdermal Products
4.1.4.1. Transdermal Patches
4.1.4.2. Transdermal Semi-Solids
4.2. Global Topical Drug Delivery Market By Route of Administration
4.2.1. Dermal Drug Delivery
4.2.2. Ophthalmic Drug Delivery
4.2.3. Rectal Drug Delivery
4.2.4. Vaginal Drug Delivery
4.2.5. Nasal Drug Delivery
4.3. Global Topical Drug Delivery Market By Facility of Use
4.3.1. Home Care Settings
4.3.2. Hospitals & Clinics
4.3.3. Burn Centers
4.3.4. Other Facilities
5. Regional Analysis
5.1. North America
5.1.1. US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. 3M Co.
6.2. Akorn Operating Co. LLC
6.3. Bausch Health Companies Inc.
6.4. Bayer AG
6.5. Boehringer Ingelheim International GmbH
6.6. CMP Pharma, Inc.
6.7. Cipla
6.8. Crescita Therapeutics Inc.
6.9. Galderma SA
6.10. Hisamitsu Pharmaceutical Co., Inc.
6.11. Ingenus Pharmaceuticals, LLC
6.12. Lavipharm
6.13. Lead Chemical Co. Ltd.
6.14. MedPharm
6.15. ProSolus, Inc
6.16. Rusan Pharma Ltd.
6.17. Sun Pharmaceutical Industries Ltd.
6.18. Viatris Inc.
1. GLOBAL TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY PRODUCTS, 2021-2028 ($ MILLION)
2. GLOBAL TOPICAL DRUG DELIVERY OF SEMI-SOLID FORMULATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL TOPICAL DRUG DELIVERY OF LIQUID FORMULATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL TOPICAL DRUG DELIVERY OF SOLID FORMULATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL TOPICAL DRUG DELIVERY OF TRANSDERMAL PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
7. GLOBAL DERMAL TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL OPHTHALMIC TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL RECTAL TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL VAGINAL TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL TOPICAL NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY FACILITY OF USE, 2021-2028 ($ MILLION)
13. GLOBAL TOPICAL DRUG DELIVERY IN HOME CARE SETTINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL TOPICAL DRUG DELIVERY IN HOSPITALS & CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL TOPICAL DRUG DELIVERY IN BURN CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
16. GLOBAL TOPICAL DRUG DELIVERY IN OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
17. GLOBAL TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
18. NORTH AMERICAN TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19. NORTH AMERICAN TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY PRODUCTS, 2021-2028 ($ MILLION)
20. NORTH AMERICAN TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
21. NORTH AMERICAN TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY FACILITY OF USE, 2021-2028 ($ MILLION)
22. EUROPEAN TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
23. EUROPEAN TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY PRODUCTS, 2021-2028 ($ MILLION)
24. EUROPEAN TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
25. EUROPEAN TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY FACILITY OF USE, 2021-2028 ($ MILLION)
26. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
27. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY PRODUCTS, 2021-2028 ($ MILLION)
28. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
29. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY FACILITY OF USE, 2021-2028 ($ MILLION)
30. REST OF THE WORLD TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
31. REST OF THE WORLD TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY PRODUCTS, 2021-2028 ($ MILLION)
32. REST OF THE WORLD TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
33. REST OF THE WORLD TOPICAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY FACILITY OF USE, 2021-2028 ($ MILLION)?
1. GLOBAL TOPICAL DRUG DELIVERY MARKET SHARE BY PRODUCTS, 2021 VS 2028 (%)
2. GLOBAL TOPICAL DRUG DELIVERY MARKET SHARE BY SEMI-SOLID FORMULATIONS, 2021 VS 2028 (%)
3. GLOBAL TOPICAL DRUG DELIVERY OF CREAMS MARKET SHARE BY REGION, 2021 VS 2028 (%)
4. GLOBAL TOPICAL DRUG DELIVERY OF OINTMENTS MARKET SHARE BY REGION, 2021 VS 2028 (%)
5. GLOBAL TOPICAL DRUG DELIVERY OF LOTIONS MARKET SHARE BY REGION, 2021 VS 2028 (%)
6. GLOBAL TOPICAL DRUG DELIVERY OF GEL MARKET SHARE BY REGION, 2021 VS 2028 (%)
7. GLOBAL TOPICAL DRUG DELIVERY OF PASTES MARKET SHARE BY REGION, 2021 VS 2028 (%)
8. GLOBAL TOPICAL DRUG DELIVERY MARKET SHARE BY LIQUID FORMULATIONS, 2021 VS 2028 (%)
9. GLOBAL TOPICAL DRUG DELIVERY OF SUSPENSIONS MARKET SHARE BY REGION, 2021 VS 2028 (%)
10. GLOBAL TOPICAL DRUG DELIVERY OF SOLUTIONS MARKET SHARE BY REGION, 2021 VS 2028 (%)
11. GLOBAL TOPICAL DRUG DELIVERY MARKET SHARE BY SOLID FORMULATIONS, 2021 VS 2028 (%)
12. GLOBAL TOPICAL DRUG DELIVERY OF POWDERS MARKET SHARE BY REGION, 2021 VS 2028 (%)
13. GLOBAL TOPICAL DRUG DELIVERY OF SUPPOSITORIES MARKET SHARE BY REGION, 2021 VS 2028 (%)
14. GLOBAL TOPICAL DRUG DELIVERY MARKET SHARE BY TRANSDERMAL PRODUCTS, 2021 VS 2028 (%)
15. GLOBAL TOPICAL DRUG DELIVERY OF TRANSDERMAL PATCHES MARKET SHARE BY REGION, 2021 VS 2028 (%)
16. GLOBAL TOPICAL DRUG DELIVERY OF TRANSDERMAL SEMI-SOLIDS MARKET SHARE BY REGION, 2021 VS 2028 (%)
17. GLOBAL TOPICAL DRUG DELIVERY MARKET SHARE BY ROUTE OF ADMINISTRATION, 2021 VS 2028 (%)
18. GLOBAL DERMAL TOPICAL DRUG DELIVERY MARKET SHARE BY REGION, 2021 VS 2028 (%)
19. GLOBAL OPHTHALMIC TOPICAL DRUG DELIVERY MARKET SHARE BY REGION, 2021 VS 2028 (%)
20. GLOBAL RECTAL TOPICAL DRUG DELIVERY MARKET SHARE BY REGION, 2021 VS 2028 (%)
21. GLOBAL VAGINAL TOPICAL DRUG DELIVERY MARKET SHARE BY REGION, 2021 VS 2028 (%)
22. GLOBAL NASAL TOPICAL DRUG DELIVERY MARKET SHARE BY REGION, 2021 VS 2028 (%)
23. GLOBAL TOPICAL DRUG DELIVERY IN HOME CARE SETTINGS MARKET SHARE BY FACILITY OF USE, 2021 VS 2028 (%)
24. GLOBAL TOPICAL DRUG DELIVERY IN HOSPITALS & CLINICS MARKET SHARE BY REGION, 2021 VS 2028 (%)
25. GLOBAL TOPICAL DRUG DELIVERY IN BURN CENTERS MARKET SHARE BY REGION, 2021 VS 2028 (%)
26. GLOBAL TOPICAL DRUG DELIVERY IN OTHER MARKET SHARE BY REGION, 2021 VS 2028 (%)
27. GLOBAL TOPICAL DRUG DELIVERY MARKET SHARE BY REGION, 2021 VS 2028 (%)
28. GLOBAL TOPICAL DRUG DELIVERY MARKET SHARE BY REGION, 2021 VS 2028 (%)
29. US TOPICAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
30. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
31. UK TOPICAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
32. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
33. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
34. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
35. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
36. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
37. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
38. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
39. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
40. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
41. REST OF ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
42. REST OF THE WORLD TOPICAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
